Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
BioCardia, Inc. (BCDA)
USD0.88
+0.07 (+9.25%)
US NASDAQ Healthcare Biotechnology
Address
320 Soquel Way 94085
Sunnyvale, CA, US
Sunnyvale, CA, US
CEO
Peter A. Altman
Website
biocardia.com
IPO
1996-11-13
CIK 925741 ISIN US09060U6064
Also trades on
NASDAQ Capital Market · BCDA (USD)
NASDAQ Capital Market · BCDAW (USD)
Description
BioCardia, Inc. is a pioneering clinical-stage company dedicated to regenerative medicine, focusing on the development of advanced cellular and cell-derived therapies for a range of cardiac and respiratory ailments. Central to its pipeline is the CardiAMP Cell Therapy System, designed to address heart failure and chronic myocardial ischemia. Additionally, BioCardia is advancing an allogeneic cell therapy program, also targeting cardiac and pulmonary conditions. The company is further exploring a specific allogeneic cell therapeutic platform. This investigational treatment, derived from culture-expanded mesenchymal cells sourced from bone marrow, is currently undergoing Phase I/II trials for patients suffering from ischemic systolic heart failure. Beyond its therapeutic candidates, BioCardia also provides innovative delivery solutions. These include the Helix biotherapeutic delivery system, engineered to precisely administer treatments directly into the heart muscle via an internal penetrating helical needle, and a line of Morph deflectable guides and sheaths. BioCardia maintains its headquarters in Sunnyvale, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.88
+0.07 (+9.25%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
3M
Beta
0.50
Float Shares
4.16M
Free Float %
71.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.34% | -5.61% | -14.41% | -13.68% | -17.21% | -19.20% | -54.09% | -98.68% | -99.35% | -99.84% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (5 ratings, all time)
Buy
Price Targets & DCF
Current price
0.88
DCF (Unlevered)
0.21
-76.3%
DCF (Levered)
0.30
-66.3%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-154.46
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-100.0%
-
EPS growth Biotechnology: +29.7%+57.6% ★ Q1'26: +78.8% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: +564.7% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+143.0% Q1'26: +294.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.07× Q1'26: -0.05× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
710.0K
est: 578.3K (+22.8%)
|
145.0K
est: 268.5K (-46.0%)
|
1.02M
est: 615.3K (+65.0%)
|
1.35M
est: 1.27M (+6.5%)
|
477.0K
est: 428.0K (+11.4%)
|
58.0K
est: 91.5K (-36.6%)
|
—
est: 50.0K (-100.0%)
|
50.0K
50.0K – 50.0K
+0.0% YoY
|
50.0K
50.0K – 50.0K
+0.0% YoY
|
4.15M
4.15M – 4.15M
+8,200.0% YoY
|
| EBITDA |
-14.05M
est: -578.3K (-2,328.7%)
|
-14.44M
est: -268.5K (-5,276.2%)
|
-12.57M
est: -615.3K (-1,943.1%)
|
-11.82M
est: -1.27M (-831.1%)
|
-11.56M
est: -256.8K (-4,401.6%)
|
-7.93M
est: -54.9K (-14,351.7%)
|
-7.77M
est: -30.0K (-25,810.0%)
|
-30.0K
-30.0K – -30.0K
+0.0% YoY
|
-30.0K
-30.0K – -30.0K
+0.0% YoY
|
-2.49M
-2.49M – -2.49M
-8,200.0% YoY
|
| EBIT |
-14.60M
est: -578.3K (-2,424.0%)
|
-15.00M
est: -268.5K (-5,487.0%)
|
-12.63M
est: -615.3K (-1,952.8%)
|
-11.90M
est: -1.27M (-837.6%)
|
-11.64M
est: -256.8K (-4,434.3%)
|
-8.00M
est: -54.9K (-14,473.8%)
|
-8.28M
est: -30.0K (-27,493.3%)
|
-30.0K
-30.0K – -30.0K
+0.0% YoY
|
-30.0K
-30.0K – -30.0K
+0.0% YoY
|
-2.49M
-2.49M – -2.49M
-8,200.0% YoY
|
| Net Income |
-14.71M
est: -95.63M (+84.6%)
|
-15.00M
est: -66.58M (+77.5%)
|
-12.62M
est: -26.86M (+53.0%)
|
-11.91M
est: -27.44M (+56.6%)
|
-11.57M
est: -35.13M (+67.1%)
|
-7.95M
est: -20.73M (+61.7%)
|
-8.23M
est: -8.00M (-2.8%)
|
-4.20M
-4.20M – -4.20M
+47.5% YoY
|
-3.37M
-3.37M – -3.37M
+19.8% YoY
|
-2.60M
-2.67M – -2.53M
+22.8% YoY
|
| SGA |
6.00M
est: 5.26M (+14.2%)
|
5.86M
est: 2.44M (+140.2%)
|
5.09M
est: 5.59M (-9.0%)
|
—
est: 11.53M (-100.0%)
|
—
est: 514.6K (-100.0%)
|
—
est: 110.0K (-100.0%)
|
3.32M
est: 60.1K (+5,415.8%)
|
60.1K
60.1K – 60.1K
+0.0% YoY
|
60.1K
60.1K – 60.1K
+0.0% YoY
|
4.99M
4.99M – 4.99M
+8,200.0% YoY
|
| EPS |
-39.15
est: -34.85 (-12.3%)
|
-22.20
est: -24.26 (+8.5%)
|
-11.19
est: -9.79 (-14.3%)
|
-10.05
est: -10.00 (-0.5%)
|
-8.19
est: -5.27 (-55.4%)
|
-2.90
est: -3.11 (+6.8%)
|
-1.23
est: -1.20 (-2.5%)
|
-0.63
-0.63 – -0.63
+47.5% YoY
|
-0.51
-0.51 – -0.51
+19.8% YoY
|
-0.39
-0.40 – -0.38
+22.8% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C+ | 2/5 | 3/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-12 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-11 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-7.48M
OE per share TTM
-0.98
Owner's Yield
-68.54%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
228.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
4
Beneficial owners (>5%)
23
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 46-0464745 | 149.73M | 65.00% | — | 149.73M | — | 10.00 | OO | Florida | 2016-05-17 | ↗ |
| 2 | Frost Gamma Investments Trust 46-0464745 | 149.73M | 32.70% | — | 149.73M | — | 149.73M | OO | Florida | 2016-11-10 | ↗ |
| 3 | Phillip Frost, M.D. | 149.73M | 32.70% | — | 149.73M | — | 149.73M | IN | United States | 2016-11-10 | ↗ |
| 4 | (2) | 24.25M | 5.30% | 24.25M | — | 24.25M | — | CO | Delaware | 2017-01-03 | ↗ |
| 5 | OPKO Health, Inc. | 2.24M | 5.80% | 2.24M | — | 2.24M | — | CO | Delaware | 2019-02-14 | ↗ |
| 6 | Thomas A. Satterfield, Jr. | 1.14M | 5.60% | 153.0K | 986.6K | 153.0K | 986.6K | IN | — | 2023-08-07 | ↗ |
| 7 | John Francis | 1.06M | 6.30% | 100.0K | 957.5K | 100.0K | — | HC, IN | — | 2022-02-14 | ↗ |
| 8 | James C. Roumell ("Roumell") | 938.4K | 5.60% | 938.4K | — | 938.4K | 11.00 | IN | — | 2021-09-22 | ↗ |
| 9 | Catalysis Partners, LLC | 927.5K | 5.50% | — | 927.5K | — | — | PN | — | 2022-02-14 | ↗ |
| 10 | Francis Capital Management, LLC | 927.5K | 5.50% | — | 927.5K | — | — | IA, HC, OO | — | 2022-02-14 | ↗ |
| 11 | Joseph P Daly | 758.5K | 3.75% | 9.1K | — | 758.5K | — | IN | — | 2023-05-25 | ↗ |
| 12 | Gerald P. Peters | 592.5K | 8.60% | 531.8K | 60.7K | 531.8K | — | IN | Number of | 2019-10-18 | ↗ |
| 13 | Sabiah Ltd. | 583.9K | 8.50% | 583.9K | — | 583.9K | — | FI | Number of | 2019-09-23 | ↗ |
| 14 | James C. Roumell (Roumell) | 556.3K | 3.30% | 556.3K | — | 556.3K | 11.00 | IN | — | 2022-02-07 | ↗ |
| 15 | Roumell Asset Management, LLC ("RAM") | 556.3K | 3.30% | 556.3K | — | 556.3K | 11.00 | IA | — | 2022-02-07 | ↗ |
| 16 | EssigPR Inc. | 301.0K | 1.49% | 9.1K | — | 301.0K | — | CO | — | 2023-05-25 | ↗ |
| 17 | Daniel B. Asher | 185.7K | 4.99% | — | 185.7K | — | 185.7K | HC, IN | United States of America | 2024-09-06 | ↗ |
| 18 | Intracoastal Capital LLC | 185.7K | 4.99% | — | 185.7K | — | 185.7K | OO | Delaware | 2024-09-06 | ↗ |
| 19 | Mitchell P. Kopin | 185.7K | 4.99% | — | 185.7K | — | 185.7K | HC, IN | United States of America | 2024-09-06 | ↗ |
| 20 | Karina Daly | 45.1K | 0.22% | 9.1K | — | 45.1K | — | IN | — | 2023-05-25 | ↗ |
| 21 | Altium Capital Management, LP | — | 0.00% | — | — | — | — | IA, PN | Delaware, United States of America | 2021-02-11 | ↗ |
| 22 | Altium Growth Fund, LP | — | 0.00% | — | — | — | — | PN | Delaware, United States of America | 2021-02-11 | ↗ |
| 23 | Altium Growth GP, LLC | — | 0.00% | — | — | — | — | OO | Delaware, United States of America | 2021-02-11 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | CM MANAGEMENT, LLC | 130.0K +— (+0.0%) | 157.3K -5.2K (-3.2%) | 1.20% -0.748 pp | 0.13% -0.006 pp | USD2.22 -45.5% | 6 qtrs — |
| 2 | — | 124.6K +124.6K (+100.0%) | 150.8K +150.8K (+100.0%) | 1.15% +1.152 pp | 0.00% +0.000 pp | USD1.21 +0.0% | 1 qtrs NEW |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 94.3K +28.3K (+42.9%) | 114.1K +31.6K (+38.3%) | 0.87% -0.118 pp | 0.00% +0.000 pp | USD1.76 -31.3% | 8 qtrs — |
| 4 | VANGUARD FIDUCIARY TRUST CO | 66.3K +66.3K (+100.0%) | 80.2K +80.2K (+100.0%) | 0.61% +0.613 pp | 0.00% +0.000 pp | USD1.21 +0.0% | 1 qtrs NEW |
| 5 | CITADEL ADVISORS LLC | 63.4K -30.9K (-32.7%) | 76.7K -41.1K (-34.9%) | 0.59% -0.827 pp | 0.00% +0.000 pp | USD1.25 -3.2% | 2 qtrs — |
| 6 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 38.8K +18.0 (+0.0%) | 47.0K -1.5K (-3.2%) | 0.36% -0.223 pp | 0.00% +0.000 pp | USD2.90 -58.3% | 8 qtrs — |
| 7 | PINGORA PARTNERS LLC | 35.7K +32.7K (+1,077.2%) | 43.2K +39.4K (+1,039.5%) | 0.33% +0.285 pp | 0.03% +0.023 pp | USD1.26 -4.0% | 8 qtrs — |
| 8 | BROWN ADVISORY INC | 35.5K +— (+0.0%) | 43.0K -1.4K (-3.2%) | 0.33% -0.204 pp | 0.00% +0.000 pp | USD2.54 -52.4% | 5 qtrs — |
| 9 | XTX TOPCO LTD | 24.3K +8.0K (+49.0%) | 29.4K +9.0K (+44.2%) | 0.22% -0.020 pp | 0.00% +0.000 pp | USD1.26 -4.0% | 3 qtrs — |
| 10 | VIRTU FINANCIAL LLC | 20.4K +20.4K (+100.0%) | 25.0K +25.0K (+100.0%) | 0.19% +0.188 pp | 0.00% +0.001 pp | USD1.21 +0.0% | 1 qtrs NEW |
| 11 | COMMONWEALTH EQUITY SERVICES, LLC | 18.3K +— (+0.0%) | 22.1K -730.0 (-3.2%) | 0.17% -0.105 pp | 0.00% +0.000 pp | USD2.45 -50.6% | 5 qtrs — |
| 12 | TWO SIGMA SECURITIES, LLC | 14.8K +14.8K (+100.0%) | 17.9K +17.9K (+100.0%) | 0.14% +0.137 pp | 0.00% +0.002 pp | USD1.21 +0.0% | 3 qtrs — |
| 13 | RENAISSANCE TECHNOLOGIES LLC | 13.9K +13.9K (+100.0%) | 16.8K +16.8K (+100.0%) | 0.13% +0.129 pp | 0.00% +0.000 pp | USD1.21 +0.0% | 1 qtrs NEW |
| 14 | MORGAN STANLEY | 3.1K +— (+0.0%) | 3.8K -124.0 (-3.2%) | 0.03% -0.018 pp | 0.00% +0.000 pp | USD2.19 -44.7% | 8 qtrs — |
| 15 | TOWER RESEARCH CAPITAL LLC (TRC) | 3.0K -316.0 (-9.6%) | 3.6K -515.0 (-12.5%) | 0.03% -0.022 pp | 0.00% +0.000 pp | USD1.25 -3.2% | 3 qtrs — |
| 16 | VANGUARD GLOBAL ADVISERS, LLC | 268.00 +268.0 (+100.0%) | 324.00 +324.0 (+100.0%) | 0.00% +0.003 pp | 0.00% +0.000 pp | USD1.21 +0.0% | 1 qtrs NEW |
| 17 | SBI SECURITIES CO., LTD. | 9.00 +3.0 (+50.0%) | 11.00 +3.0 (+37.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.56 -22.4% | 6 qtrs — |
| 18 | ADVISOR GROUP HOLDINGS, INC. | 1.00 +— (+0.0%) | 1.00 +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 -59.7% | 7 qtrs — |
| 19 | UBS GROUP AG | — -4.4K (-100.0%) | — -5.5K (-100.0%) | 0.00% -0.066 pp | 0.00% +0.000 pp | USD— | 6 qtrs SOLD |
| 20 | TWO SIGMA INVESTMENTS, LP | — -11.2K (-100.0%) | — -14.0K (-100.0%) | 0.00% -0.168 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 21 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | — -20.0K (-100.0%) | — -25.4K (-100.0%) | 0.00% -0.300 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 22 | GSA CAPITAL PARTNERS LLP | — -11.3K (-100.0%) | — -14.0K (-100.0%) | 0.00% -0.170 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 23 | DRW SECURITIES, LLC | — -57.6K (-100.0%) | — -72.0K (-100.0%) | 0.00% -0.864 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 11 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 62.7K | 0.05% |
| 2 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 109.33 | 0.03% |
| 3 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 300.19 | 0.17% |
| 4 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 22.17 | 0.17% |
| 5 | Vanguard Total Stock Market ETF VTI | 0.00% | 51.3K | 0.03% |
| 6 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 112.83 | 0.22% |
| 7 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 61.59 | 0.22% |
| 8 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 24.80 | 0.22% |
| 9 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 2.70 | 0.22% |
| 10 | Vanguard Conservative Income ETF Portfolio VCIP.TO | 0.00% | 0.38 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
4
Sells
0
Shares acquired
11.1K
Shares disposed
—
Cash buys
4.00
Cash sales
—
Net activity
+11,100
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 5,100 | 1.02 | 5.2K | 285,866 | D | ↗ |
| 2026-04-29 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 1.11 | 5.6K | 280,766 | D | ↗ |
| 2026-04-21 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 400 | 1.23 | 492.00 | 275,766 | D | ↗ |
| 2026-04-20 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 600 | 1.23 | 738.00 | 275,366 | D | ↗ |
| 2026-03-25 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 300 | 1.22 | 366.00 | 274,766 | D | ↗ |
| 2026-03-24 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 600 | 1.24 | 744.00 | 274,466 | D | ↗ |
| 2026-02-04 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 1.13 | 5.7K | 273,866 | D | ↗ |
| 2026-01-21 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 300 | 1.34 | 402.00 | 268,866 | D | ↗ |
| 2026-01-20 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 600 | 1.32 | 792.00 | 268,566 | D | ↗ |
| 2025-12-17 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 900 | 1.30 | 1.2K | 267,966 | D | ↗ |
| 2025-12-16 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 200 | 1.37 | 274.00 | 267,066 | D | ↗ |
| 2025-12-08 | Slosman Marvin | Director | A-Award | A | Stock Option (right to buy) | 12,000 | 1.37 | 16.4K | 12,000 | D | ↗ |
| 2025-12-08 | STERTZER SIMON H | Director | A-Award | A | Stock Option (right to buy) | 12,000 | 1.37 | 16.4K | 15,573 | D | ↗ |
| 2025-12-08 | McClung David | Officer | F-InKind | A | Common Stock | 29,339 | 1.37 | 40.2K | 76,887 | D | ↗ |
| 2025-12-08 | MOYES JAY M | Director | A-Award | A | Stock Option (right to buy) | 12,000 | 1.37 | 16.4K | 15,573 | D | ↗ |
| 2025-12-08 | GILLIS EDWARD M | Officer | F-InKind | A | Common Stock | 15,172 | 1.37 | 20.8K | 31,874 | D | ↗ |
| 2025-12-08 | Facteau Bill | Director | A-Award | A | Stock Option (right to buy) | 12,000 | 1.37 | 16.4K | 15,729 | D | ↗ |
| 2025-12-08 | Blank Andrew Scott | Director | A-Award | A | Stock Option (right to buy) | 12,000 | 1.37 | 16.4K | 15,313 | D | ↗ |
| 2025-12-08 | Altman Peter | Director / Officer | A-Award | A | Stock Option (right to buy) | 38,000 | 1.37 | 52.1K | 90,215 | D | ↗ |
| 2025-12-08 | Allen Jim L. | Director | A-Award | A | Stock Option (right to buy) | 12,000 | 1.37 | 16.4K | 15,313 | D | ↗ |
| 2025-12-02 | Slosman Marvin | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-09-19 | STERTZER SIMON H | Director | P-Purchase | A | Common Stock | 398,400 | 1.25 | 498.0K | 591,054 | I | ↗ |
| 2025-09-19 | Blank Andrew Scott | Director | P-Purchase | A | Common Stock | 288,000 | 1.25 | 360.0K | 634,023 | I | ↗ |
| 2025-09-19 | Altman Peter | Director / Officer | P-Purchase | A | Warrant (right to buy) | 48,000 | 1.25 | 60.0K | 143,612 | D | ↗ |
| 2025-08-22 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 700 | 1.83 | 1.3K | 168,762 | D | ↗ |
| 2025-08-13 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 100 | 1.83 | 183.00 | 168,062 | D | ↗ |
| 2025-08-12 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 400 | 1.75 | 700.40 | 167,962 | D | ↗ |
| 2025-08-11 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 1,700 | 1.76 | 3.0K | 167,562 | D | ↗ |
| 2025-06-30 | STERTZER SIMON H | Director | P-Purchase | A | Common Stock | 72,289 | 2.08 | 150.0K | 192,654 | I | ↗ |
| 2025-06-30 | McClung David | Officer | P-Purchase | A | Common Stock | 4,819 | 2.08 | 10.0K | 47,950 | D | ↗ |
| 2025-06-30 | Blank Andrew Scott | Director | P-Purchase | A | Warrant (right to buy) | 72,289 | 1.95 | 141.0K | 314,522 | I | ↗ |
| 2025-06-30 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 24,096 | 2.08 | 50.0K | 165,862 | D | ↗ |
| 2025-05-30 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 100 | 2.21 | 221.00 | 141,766 | D | ↗ |
| 2025-05-22 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 700 | 1.89 | 1.3K | 141,666 | D | ↗ |
| 2025-05-20 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 1,600 | 2.08 | 3.3K | 140,966 | D | ↗ |
| 2025-05-16 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 300 | 2.43 | 729.60 | 139,366 | D | ↗ |
| 2025-05-14 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 100 | 2.99 | 298.60 | 139,066 | D | ↗ |
| 2025-04-23 | STERTZER SIMON H | Director | P-Purchase | A | Warrant (right to buy) | 104,986 | 1.91 | 200.0K | 104,986 | I | ↗ |
| 2025-04-23 | McClung David | Officer | P-Purchase | A | Warrant (right to buy) | 13,123 | 1.91 | 25.0K | 21,456 | D | ↗ |
| 2025-04-23 | KRASNO RICHARD M | Director | P-Purchase | A | Common Stock | 13,123 | 1.91 | 25.0K | 16,268 | D | ↗ |
| 2025-04-23 | Facteau Bill | Director | P-Purchase | A | Warrant (right to buy) | 13,123 | 1.91 | 25.0K | 13,123 | D | ↗ |
| 2025-04-23 | Blank Andrew Scott | Director | P-Purchase | A | Common Stock | 131,233 | 1.91 | 250.0K | 265,957 | I | ↗ |
| 2025-04-23 | Altman Peter | Director / Officer | P-Purchase | A | Warrant (right to buy) | 26,246 | 1.91 | 50.0K | 71,516 | D | ↗ |
| 2025-04-15 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 100 | 2.14 | 214.00 | 112,720 | D | ↗ |
| 2025-04-11 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 300 | 2.03 | 609.00 | 112,620 | D | ↗ |
| 2025-04-10 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 300 | 1.99 | 597.00 | 112,320 | D | ↗ |
| 2025-04-07 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 500 | 1.96 | 980.00 | 112,020 | D | ↗ |
| 2025-04-04 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 800 | 2.04 | 1.6K | 111,520 | D | ↗ |
| 2025-04-03 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 1,200 | 2.24 | 2.7K | 109,620 | D | ↗ |
| 2025-04-02 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 500 | 2.23 | 1.1K | 110,120 | D | ↗ |
| 2025-03-05 | STERTZER SIMON H | Director | P-Purchase | A | Common Stock | 1,000 | 2.45 | 2.5K | 57,138 | D | ↗ |
| 2025-03-04 | STERTZER SIMON H | Director | P-Purchase | A | Common Stock | 15,536 | 2.30 | 35.7K | 56,138 | D | ↗ |
| 2025-03-03 | STERTZER SIMON H | Director | P-Purchase | A | Common Stock | 22,753 | 2.30 | 52.3K | 40,602 | D | ↗ |
| 2025-03-03 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 500 | 2.11 | 1.1K | 108,420 | D | ↗ |
| 2025-02-07 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 600 | 2.48 | 1.5K | 107,920 | D | ↗ |
| 2025-01-30 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 239 | 2.38 | 568.82 | 107,320 | D | ↗ |
| 2025-01-29 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 500 | 2.40 | 1.2K | 107,081 | D | ↗ |
| 2024-12-23 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 2.06 | 2.1K | 106,581 | D | ↗ |
| 2024-12-20 | GILLIS EDWARD M | Officer | S-Sale | D | Common Stock | 3,257 | 2.00 | 6.5K | 8,968 | D | ↗ |
| 2024-12-05 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 250 | 2.22 | 555.00 | 105,581 | D | ↗ |
| 2024-11-15 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 1,350 | 1.87 | 2.5K | 105,331 | D | ↗ |
| 2024-10-11 | STERTZER SIMON H | Director | A-Award | A | Stock Option (right to buy) | 829 | 2.65 | 2.2K | 3,573 | D | ↗ |
| 2024-10-11 | McClung David | Officer | F-InKind | D | Common Stock | 11,565 | 2.65 | 30.6K | 30,008 | D | ↗ |
| 2024-10-11 | MOYES JAY M | Director | A-Award | A | Stock Option (right to buy) | 829 | 2.65 | 2.2K | 3,573 | D | ↗ |
| 2024-10-11 | KRASNO RICHARD M | Director | A-Award | A | Stock Option (right to buy) | 829 | 2.65 | 2.2K | 3,313 | D | ↗ |
| 2024-10-11 | GILLIS EDWARD M | Officer | F-InKind | D | Common Stock | 6,840 | 2.65 | 18.1K | 12,225 | D | ↗ |
| 2024-10-11 | Facteau Bill | Director | A-Award | A | Stock Option (right to buy) | 829 | 2.65 | 2.2K | 3,729 | D | ↗ |
| 2024-10-11 | Blank Andrew Scott | Director | A-Award | A | Stock Option (right to buy) | 829 | 2.65 | 2.2K | 3,313 | D | ↗ |
| 2024-10-11 | Altman Peter | Director / Officer | F-InKind | D | Common Stock | 21,680 | 2.65 | 57.5K | 103,981 | D | ↗ |
| 2024-10-11 | Allen Jim L. | Director | A-Award | A | Stock Option (right to buy) | 829 | 2.65 | 2.2K | 3,313 | D | ↗ |
| 2024-09-30 | Allen Jim L. | Director | A-Award | A | Warrant (right to buy) | 50,000 | 3.00 | 150.0K | 50,000 | — | ↗ |
| 2024-09-03 | McClung David | Officer | A-Award | A | Common Stock | 8,333 | 3.00 | 25.0K | 17,380 | — | ↗ |
| 2024-09-03 | Blank Andrew Scott | Director | A-Award | A | Warrant (right to buy) | 111,000 | 3.00 | 333.0K | 111,000 | — | ↗ |
| 2024-09-03 | Altman Peter | Director / Officer | A-Award | A | Common Stock | 41,666 | 3.00 | 125.0K | 81,411 | — | ↗ |
| 2024-09-03 | Allen Jim L. | Director | A-Award | A | Common Stock | 50,000 | 3.00 | 150.0K | 109,661 | — | ↗ |
| 2024-01-19 | FROST PHILLIP MD ET AL | 10% Owner | S-Sale | D | Common Stock | 129,802 | 0.43 | 55.8K | 1,896,025 | — | ↗ |
| 2023-10-18 | STERTZER SIMON H | Director | A-Award | A | Stock Option (right to buy) | 12,434 | 0.40 | 5.0K | 47,510 | — | ↗ |
| 2023-10-18 | MOYES JAY M | Director | A-Award | A | Stock Option (right to buy) | 12,434 | 0.40 | 5.0K | 41,233 | — | ↗ |
| 2023-10-18 | KRASNO RICHARD M | Director | A-Award | A | Stock Option (right to buy) | 12,434 | 0.40 | 5.0K | 37,302 | — | ↗ |
| 2023-10-18 | Facteau Bill | Director | A-Award | A | Stock Option (right to buy) | 12,434 | 0.40 | 5.0K | 12,434 | — | ↗ |
| 2023-10-18 | Blank Andrew Scott | Director | A-Award | A | Stock Option (right to buy) | 12,434 | 0.40 | 5.0K | 37,302 | — | ↗ |
| 2023-10-18 | Allen Jim L. | Director | A-Award | A | Stock Option (right to buy) | 12,434 | 0.40 | 5.0K | 37,302 | — | ↗ |
| 2023-08-17 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 4,000 | 0.87 | 3.5K | 447,339 | — | ↗ |
| 2023-08-14 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 4,500 | 0.88 | 4.0K | 443,339 | — | ↗ |
| 2023-06-23 | STERTZER SIMON H | Director | A-Award | A | Common Stock | 64,212 | 2.34 | 150.0K | 267,766 | — | ↗ |
| 2023-06-23 | McClung David | Officer | A-Award | A | Common Stock | 4,280 | 2.34 | 10.0K | 135,724 | — | ↗ |
| 2023-06-23 | Blank Andrew Scott | Director | A-Award | A | Common Stock | 64,212 | 2.34 | 150.0K | 211,404 | — | ↗ |
| 2023-06-23 | Altman Peter | Director / Officer | A-Award | A | Common Stock | 6,421 | 2.34 | 15.0K | 438,839 | — | ↗ |
| 2023-06-23 | Allen Jim L. | Director | A-Award | A | Common Stock | 64,212 | 2.34 | 150.0K | 894,743 | — | ↗ |
| 2023-05-31 | McClung David | Officer | F-InKind | D | Common Stock | 20,676 | 1.77 | 36.6K | 131,444 | — | ↗ |
| 2023-05-31 | GILLIS EDWARD M | Officer | F-InKind | D | Common Stock | 15,512 | 1.77 | 27.5K | 48,857 | — | ↗ |
| 2023-05-31 | Altman Peter | Director / Officer | F-InKind | D | Common Stock | 36,821 | 1.77 | 65.2K | 432,418 | — | ↗ |
| 2023-05-26 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 6,200 | 1.60 | 9.9K | 469,239 | — | ↗ |
| 2023-05-18 | McClung David | Officer | A-Award | A | Common Stock | 61,389 | 1.70 | 104.4K | 152,120 | — | ↗ |
| 2023-05-18 | GILLIS EDWARD M | Officer | A-Award | A | Stock Option (right to buy) | 43,803 | 1.70 | 74.5K | 43,803 | — | ↗ |
| 2023-05-18 | Altman Peter | Director / Officer | A-Award | A | Common Stock | 109,324 | 1.70 | 185.9K | 463,039 | — | ↗ |
| 2022-12-16 | STERTZER SIMON H | Director | A-Award | A | Common Stock | 178,571 | 1.68 | 300.0K | 888,084 | — | ↗ |
| 2022-12-16 | McClung David | Officer | A-Award | A | Common Stock | 8,928 | 1.68 | 15.0K | 87,446 | — | ↗ |
| 2022-12-16 | FROST PHILLIP MD ET AL | Director | P-Purchase | A | Common Stock | 595,238 | 1.68 | 1,000.0K | 2,025,827 | — | ↗ |
| 2022-12-16 | Blank Andrew Scott | Director | A-Award | A | Common Stock | 148,809 | 1.68 | 250.0K | 291,659 | — | ↗ |
| 2022-12-16 | Altman Peter | Officer | A-Award | A | Common Stock | 14,880 | 1.68 | 25.0K | 347,827 | — | ↗ |
| 2022-12-16 | Allen Jim L. | Director | A-Award | A | Common Stock | 148,809 | 1.68 | 250.0K | 830,531 | — | ↗ |
| 2022-11-11 | Altman Peter | Officer | P-Purchase | A | Common Stock | 1,400 | 1.86 | 2.6K | 332,947 | — | ↗ |
| 2022-11-10 | Altman Peter | Officer | P-Purchase | A | Common Stock | 3,100 | 1.87 | 5.8K | 331,547 | — | ↗ |
| 2022-10-10 | McClung David | Officer | P-Purchase | A | Common Stock | 2,000 | 2.07 | 4.1K | 78,518 | — | ↗ |
| 2022-09-23 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 1,400 | 1.87 | 2.6K | 328,447 | — | ↗ |
| 2022-09-22 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 3,100 | 1.81 | 5.6K | 327,047 | — | ↗ |
| 2022-09-21 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 2,750 | 1.92 | 5.3K | 323,947 | — | ↗ |
| 2022-05-13 | Altman Peter | Director / Officer | A-Award | D | Common Stock | 3,498 | 1.37 | 4.8K | 348,943 | — | ↗ |
| 2022-05-12 | McClung David | Officer | A-Award | D | Common Stock | 17,347 | 1.32 | 22.9K | 79,803 | — | ↗ |
| 2022-05-12 | Altman Peter | Director / Officer | F-InKind | D | Common Stock | 26,458 | 1.32 | 34.9K | 321,685 | — | ↗ |
| 2022-04-14 | ZSEBO KRISZTINA M | Director | A-Award | A | Stock Option (right to buy) | 31,085 | 1.49 | 46.3K | 55,953 | — | ↗ |
| 2022-01-11 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 100 | 1.87 | 187.00 | 353,715 | — | ↗ |
| 2021-11-18 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 2.20 | 11.0K | 237,909 | — | ↗ |
| 2021-08-17 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 3,500 | 2.94 | 10.3K | 232,909 | — | ↗ |
| 2021-06-15 | ZSEBO KRISZTINA M | Director | A-Award | A | Stock Option (right to buy) | 12,434 | 4.43 | 55.1K | 12,434 | — | ↗ |
| 2021-06-15 | STERTZER SIMON H | Director | A-Award | A | Stock Option (right to buy) | 12,434 | 4.43 | 55.1K | 22,642 | — | ↗ |
| 2021-06-15 | MOYES JAY M | Director | A-Award | A | Stock Option (right to buy) | 12,434 | 4.43 | 55.1K | 16,355 | — | ↗ |
| 2021-06-15 | KRASNO RICHARD M | Director | A-Award | A | Stock Option (right to buy) | 12,434 | 4.43 | 55.1K | 12,434 | — | ↗ |
| 2021-06-15 | Blank Andrew Scott | Director | A-Award | A | Stock Option (right to buy) | 12,434 | 4.43 | 55.1K | 12,434 | — | ↗ |
| 2021-06-15 | Allen Jim L. | Director | A-Award | A | Stock Option (right to buy) | 12,434 | 4.43 | 55.1K | 12,434 | — | ↗ |
| 2021-06-10 | McClung David | Officer | F-InKind | D | Common Stock | 7,274 | 4.35 | 31.6K | 46,805 | — | ↗ |
| 2021-06-10 | GILLIS EDWARD M | Officer | F-InKind | D | Common Stock | 9,953 | 4.35 | 43.3K | 6,082 | — | ↗ |
| 2021-06-10 | Altman Peter | Director / Officer | F-InKind | D | Common Stock | 11,572 | 4.35 | 50.3K | 229,409 | — | ↗ |
| 2021-04-21 | McClung David | Officer | A-Award | A | Stock Option (right to buy) | 75,850 | 3.49 | 264.7K | 75,850 | — | ↗ |
| 2021-04-21 | GILLIS EDWARD M | Officer | A-Award | A | Stock Option (right to buy) | 48,670 | 3.49 | 169.9K | 48,670 | — | ↗ |
| 2021-04-21 | Altman Peter | Director / Officer | A-Award | D | Common Stock | 33,581 | 0.00 | — | 240,981 | — | ↗ |
| 2021-03-31 | ZSEBO KRISZTINA M | Director | A-Award | A | Common Stock | 2,736 | 0.00 | — | 2,980 | — | ↗ |
| 2021-03-31 | STERTZER SIMON H | Director / 10% Owner | A-Award | A | Common Stock | 2,304 | 0.00 | — | 203,554 | — | ↗ |
| 2021-03-31 | MOYES JAY M | Director | A-Award | A | Common Stock | 3,456 | 0.00 | — | 54,267 | — | ↗ |
| 2021-03-31 | KRASNO RICHARD M | Director | A-Award | A | Common Stock | 3,024 | 0.00 | — | 47,187 | — | ↗ |
| 2021-03-31 | Blank Andrew Scott | Director | A-Award | A | Common Stock | 4,752 | 0.00 | — | 147,192 | — | ↗ |
| 2021-03-31 | Allen Jim L. | Director | A-Award | A | Common Stock | 2,520 | 0.00 | — | 681,722 | — | ↗ |
| 2020-12-31 | ZSEBO KRISZTINA M | Director | A-Award | A | Common Stock | 244 | 0.00 | — | 244 | — | ↗ |
| 2020-12-31 | STERTZER SIMON H | Director / 10% Owner | A-Award | A | Common Stock | 2,968 | 0.00 | — | 201,250 | — | ↗ |
| 2020-12-31 | PFENNIGER RICHARD C JR | Director | A-Award | A | Common Stock | 2,800 | 0.00 | — | 48,845 | — | ↗ |
| 2020-12-31 | MOYES JAY M | Director | A-Award | A | Common Stock | 2,800 | 0.00 | — | 47,061 | — | ↗ |
| 2020-12-31 | KRASNO RICHARD M | Director | A-Award | A | Common Stock | 2,734 | 0.00 | — | 44,163 | — | ↗ |
| 2020-12-31 | Blank Andrew Scott | Director | A-Award | A | Common Stock | 2,800 | 0.00 | — | 137,597 | — | ↗ |
| 2020-12-31 | Allen Jim L. | Director | A-Award | A | Common Stock | 2,800 | 0.00 | — | 676,468 | — | ↗ |
| 2020-12-22 | ZSEBO KRISZTINA M | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-01 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 2.49 | 2.5K | 207,400 | — | ↗ |
| 2020-11-27 | Altman Peter | Director / Officer | S-Sale | D | Common Stock | 3,200 | 2.31 | 7.4K | 203,200 | — | ↗ |
| 2020-11-13 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 500 | 2.09 | 1.0K | 206,400 | — | ↗ |
| 2020-11-12 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 2,000 | 2.07 | 4.1K | 205,900 | — | ↗ |
| 2020-11-10 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 1.98 | 5.0K | 203,900 | — | ↗ |
| 2020-11-02 | Duckers Eric | Officer | S-Sale | D | Common Stock | 8,435 | 2.01 | 17.0K | 12,088 | — | ↗ |
| 2020-09-30 | STERTZER SIMON H | Director / 10% Owner | A-Award | A | Common Stock | 2,968 | 0.00 | — | 195,482 | — | ↗ |
| 2020-09-30 | PFENNIGER RICHARD C JR | Director | A-Award | A | Common Stock | 3,125 | 0.00 | — | 46,045 | — | ↗ |
| 2020-09-30 | MOYES JAY M | Director | A-Award | A | Common Stock | 3,750 | 0.00 | — | 44,261 | — | ↗ |
| 2020-09-30 | KRASNO RICHARD M | Director | A-Award | A | Common Stock | 2,734 | 0.00 | — | 38,629 | — | ↗ |
| 2020-09-30 | FERNANDEZ FERNANDO L | Director | A-Award | A | Common Stock | 2,968 | 0.00 | — | 40,644 | — | ↗ |
| 2020-09-30 | Blank Andrew Scott | Director | A-Award | A | Common Stock | 4,843 | 0.00 | — | 134,797 | — | ↗ |
| 2020-09-30 | Allen Jim L. | Director | A-Award | A | Common Stock | 2,734 | 0.00 | — | 673,668 | — | ↗ |
| 2020-06-30 | STERTZER SIMON H | Director / 10% Owner | A-Award | A | Common Stock | 4,531 | 0.00 | — | 192,514 | — | ↗ |
| 2020-06-30 | Pesta Phil | Officer | F-InKind | D | Common Stock | 6,185 | 2.40 | 14.8K | 11,867 | — | ↗ |
| 2020-06-30 | PFENNIGER RICHARD C JR | Director | A-Award | A | Common Stock | 3,125 | 0.00 | — | 42,920 | — | ↗ |
| 2020-06-30 | McClung David | Officer | F-InKind | D | Common Stock | 7,895 | 2.40 | 18.9K | 32,709 | — | ↗ |
| 2020-06-30 | MOYES JAY M | Director | A-Award | A | Common Stock | 3,750 | 0.00 | — | 40,511 | — | ↗ |
| 2020-06-30 | KRASNO RICHARD M | Director | A-Award | A | Common Stock | 2,734 | 0.00 | — | 35,895 | — | ↗ |
| 2020-06-30 | FERNANDEZ FERNANDO L | Director | A-Award | A | Common Stock | 2,968 | 0.00 | — | 37,676 | — | ↗ |
| 2020-06-30 | Duckers Eric | Officer | F-InKind | D | Common Stock | 7,154 | 2.40 | 17.2K | 20,523 | — | ↗ |
| 2020-06-30 | Blank Andrew Scott | Director | A-Award | A | Common Stock | 3,281 | 0.00 | — | 129,954 | — | ↗ |
| 2020-06-30 | Altman Peter | Director / Officer | F-InKind | D | Common Stock | 15,159 | 2.40 | 36.4K | 201,400 | — | ↗ |
| 2020-06-30 | Allen Jim L. | Director | A-Award | A | Common Stock | 2,734 | 0.00 | — | 670,934 | — | ↗ |
| 2020-06-19 | STERTZER SIMON H | Director / 10% Owner | P-Purchase | A | Common Stock | 142,850 | 2.10 | 300.0K | 187,983 | — | ↗ |
| 2020-06-19 | Blank Andrew Scott | Director | P-Purchase | A | Common Stock | 142,850 | 2.10 | 300.0K | 142,850 | — | ↗ |
| 2020-06-19 | Allen Jim L. | Director | P-Purchase | A | Common Stock | 142,850 | 2.10 | 300.0K | 668,200 | — | ↗ |
| 2020-05-08 | STERTZER SIMON H | Director / 10% Owner | A-Award | A | Common Stock | 8,800 | 0.00 | — | 45,133 | — | ↗ |
| 2020-05-08 | PFENNIGER RICHARD C JR | Director | A-Award | A | Common Stock | 8,800 | 0.00 | — | 39,795 | — | ↗ |
| 2020-05-08 | MOYES JAY M | Director | A-Award | A | Common Stock | 8,800 | 0.00 | — | 36,761 | — | ↗ |
| 2020-05-08 | KRASNO RICHARD M | Director | A-Award | A | Common Stock | 8,800 | 0.00 | — | 33,161 | — | ↗ |
| 2020-05-08 | FERNANDEZ FERNANDO L | Director | A-Award | A | Common Stock | 8,800 | 0.00 | — | 34,708 | — | ↗ |
| 2020-05-08 | Blank Andrew Scott | Director | A-Award | A | Common Stock | 4,100 | 0.00 | — | 126,673 | — | ↗ |
| 2020-05-08 | Allen Jim L. | Director | A-Award | A | Common Stock | 4,100 | 0.00 | — | 525,350 | — | ↗ |
| 2020-04-30 | STERTZER SIMON H | Director / 10% Owner | A-Award | A | Common Stock | 26,875 | 0.00 | — | 28,208 | — | ↗ |
| 2020-04-30 | PFENNIGER RICHARD C JR | Director | A-Award | A | Common Stock | 16,000 | 0.00 | — | 27,870 | — | ↗ |
| 2020-04-30 | MOYES JAY M | Director | A-Award | A | Common Stock | 20,250 | 0.00 | — | 24,211 | — | ↗ |
| 2020-04-30 | KRASNO RICHARD M | Director | A-Award | A | Common Stock | 2,734 | 0.00 | — | 24,361 | — | ↗ |
| 2020-04-30 | FERNANDEZ FERNANDO L | Director | A-Award | A | Common Stock | 2,968 | 0.00 | — | 25,908 | — | ↗ |
| 2020-04-30 | Blank Andrew Scott | Director | A-Award | A | Common Stock | 2,625 | 0.00 | — | 119,292 | — | ↗ |
| 2020-04-30 | Allen Jim L. | Director | A-Award | A | Common Stock | 2,187 | 0.00 | — | 518,516 | — | ↗ |
| 2020-04-24 | Pesta Phil | Officer | A-Award | A | Stock Option (right to buy) | 10,000 | 3.43 | 34.3K | 10,000 | — | ↗ |
| 2020-04-24 | McClung David | Officer | A-Award | A | Stock Option (right to buy) | 25,540 | 3.43 | 87.6K | 25,540 | — | ↗ |
| 2020-04-24 | Duckers Eric | Officer | A-Award | A | Stock Option (right to buy) | 25,500 | 3.43 | 87.5K | 25,500 | — | ↗ |
| 2020-04-24 | Altman Peter | Director / Officer | A-Award | A | Common Stock | 37,080 | 0.00 | — | 216,559 | — | ↗ |
| 2020-04-22 | Altman Peter | Director / Officer | A-Award | A | Common Stock | 400 | 3.41 | 1.4K | 179,479 | — | ↗ |
| 2020-03-24 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 1,200 | 2.90 | 3.5K | 171,911 | — | ↗ |
| 2020-03-19 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 400 | 2.95 | 1.2K | 170,711 | — | ↗ |
| 2020-03-18 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 3,300 | 2.53 | 8.3K | 170,311 | — | ↗ |
| 2020-03-17 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 200 | 3.66 | 732.00 | 167,011 | — | ↗ |
| 2020-03-12 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 3,400 | 3.15 | 10.7K | 166,811 | — | ↗ |
| 2020-03-11 | Pesta Phil | Officer | F-InKind | D | Common Stock | 2,023 | 3.60 | 7.3K | 2,924 | — | ↗ |
| 2020-03-11 | McClung David | Officer | F-InKind | D | Common Stock | 2,582 | 3.60 | 9.3K | 21,292 | — | ↗ |
| 2020-03-11 | Duckers Eric | Officer | F-InKind | D | Common Stock | 1,205 | 3.60 | 4.3K | 10,177 | — | ↗ |
| 2020-03-11 | Altman Peter | Director / Officer | F-InKind | D | Common Stock | 4,958 | 3.60 | 17.8K | 179,079 | — | ↗ |
| 2020-01-13 | PFENNIGER RICHARD C JR | Director | M-Exempt | D | Restricted Stock Units | 567 | 0.00 | — | 0 | — | ↗ |
| 2020-01-13 | KRASNO RICHARD M | Director | M-Exempt | D | Restricted Stock Units | 567 | 0.00 | — | 0 | — | ↗ |
| 2020-01-13 | FERNANDEZ FERNANDO L | Director | M-Exempt | A | Common Stock | 567 | 0.00 | — | 6,315 | — | ↗ |
| 2019-12-31 | Altman Peter | Director / Officer | P-Purchase | A | Common Stock | 4,000 | 3.67 | 14.7K | 163,411 | — | ↗ |
Executive team
Top executives
Shares Outstanding
5.80M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Peter Altman, Ph.D. President, Chief Executive Officer, and Director | 493.4K | — | — | — | — | — | 493.4K | 0.00% | ↗ |
| 2 | 2024 | David McClung Chief Financial Officer | 354.9K | — | — | — | — | — | 354.9K | 0.00% | ↗ |
| 3 | 2024 | Edward Gillis Senior Vice President, Devices | 251.8K | — | — | — | — | — | 251.8K | 0.00% | ↗ |
| 4 | 2023 | Peter Altman, Ph.D. President, Chief Executive Officer, and Director | 515.5K | 116.6K | — | 230.7K | — | — | 862.8K | 26.74% | ↗ |
| 5 | 2023 | David McClung Chief Financial Officer | 370.9K | 63.7K | — | 98.6K | — | — | 533.2K | 18.49% | ↗ |
| 6 | 2023 | Edward Gillis Senior Vice President, Devices | 263.1K | 41.7K | — | 63.3K | — | — | 368.0K | 17.19% | ↗ |
| 7 | 2022 | Peter Altman, Ph.D. President, Chief Executive Officer, and Director | 531.0K | — | 185.9K | 185.0K | — | — | 901.9K | 41.12% | ↗ |
| 8 | 2022 | David McClung Chief Financial Officer | 382.0K | — | 104.4K | 78.7K | — | — | 565.1K | 32.40% | ↗ |
| 9 | 2022 | Edward Gillis Senior Vice President, Devices | 271.0K | — | 68.8K | 49.9K | — | — | 389.7K | 30.46% | ↗ |
| 10 | 2020 | Peter Altman, Ph.D. President, Chief Executive Officer, and Director | 380.0K | — | 117.2K | 385.7K | — | — | 882.8K | 56.96% | ↗ |
| 11 | 2020 | David McClung Chief Financial Officer | 317.8K | — | 74.6K | 110.5K | — | — | 502.8K | 36.80% | ↗ |
| 12 | 2020 | Henricus Duckers Former Chief Medical Officer | 358.7K | — | — | 126.1K | — | — | 484.8K | 26.02% | ↗ |
| 13 | 2019 | Peter Altman, Ph.D. President, Chief Executive Officer, and Director | 362.7K | — | 127.2K | 257.2K | — | — | 671.8K | 57.22% | ↗ |
| 14 | 2019 | Henricus Duckers Former Chief Medical Officer | 350.0K | — | 60.0K | 107.9K | — | — | 524.2K | 32.04% | ↗ |
| 15 | 2019 | David McClung Chief Financial Officer | 302.3K | — | 66.2K | 102.2K | — | — | 417.1K | 40.40% | ↗ |
| 16 | 2009 | Andrew A. Brooks Chairman of the Board | 250.0K | — | — | — | — | — | 250.0K | 0.00% | ↗ |
| 17 | 2009 | Michael Kvitnitsky Chief Operating Officer | 220.0K | — | — | — | — | — | 220.0K | 0.00% | ↗ |
| 18 | 2009 | Derrick Romine Chief Financial Officer | 180.0K | — | — | — | — | — | 180.0K | 0.00% | ↗ |
| 19 | 2008 | Derrick Romine Chief Financial Officer | 165.0K | — | — | — | — | — | 226.1K | 0.00% | ↗ |
| 20 | 2008 | Michael Kvitnitsky Chief Operating Officer | 156.1K | — | — | — | — | — | 182.1K | 0.00% | ↗ |
| 21 | 2008 | Andrew A. Brooks Chairman of the Board | 104.2K | — | — | — | — | — | 133.4K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
| Filing date | Form type | Filing |
|---|---|---|
| 2025-11-03 | DEF 14A | ↗ |
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Peter A. Altman | Chief Executive Officer, President & Director | 506.7K | — |
| David McClung | Chief Financial Officer | 364.5K | male |
| Edward Gillis | Senior Vice President of Devices | 258.6K | male |
| Miranda Peto Benvenuti | Investor Relations Executive | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BCDA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
